These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bone mineral density and depot medroxyprogesterone acetate. Albertazzi P; Bottazzi M; Steel SA Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487 [TBL] [Abstract][Full Text] [Related]
4. Effects of hormonal contraception on bone mineral density after 24 months of use. Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563 [TBL] [Abstract][Full Text] [Related]
5. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections. Harel Z; Johnson CC; Gold MA; Cromer B; Peterson E; Burkman R; Stager M; Brown R; Bruner A; Coupey S; Hertweck P; Bone H; Wolter K; Nelson A; Marshall S; Bachrach LK Contraception; 2010 Apr; 81(4):281-91. PubMed ID: 20227543 [TBL] [Abstract][Full Text] [Related]
6. Low-dose oral contraceptives in adolescents: how low can you go? Agostino H; Di Meglio G J Pediatr Adolesc Gynecol; 2010 Aug; 23(4):195-201. PubMed ID: 20227307 [TBL] [Abstract][Full Text] [Related]
7. [Effect of hormonal contraception on bone mineral density]. Trémollières F Gynecol Obstet Fertil; 2005; 33(7-8):520-5. PubMed ID: 16005661 [TBL] [Abstract][Full Text] [Related]
8. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception. Beksinska ME; Smit JA; Kleinschmidt I; Farley TM; Mbatha F Contraception; 2005 Mar; 71(3):170-5. PubMed ID: 15722065 [TBL] [Abstract][Full Text] [Related]
9. [Contraception and bone health in adolescence]. Julen O; Larigaldie S; Yaron M Rev Med Suisse; 2012 Oct; 8(359):2007-8, 2010. PubMed ID: 23167074 [TBL] [Abstract][Full Text] [Related]
10. The use of depot-medroxyprogesterone acetate in contraception and its potential impact on skeletal health. Guilbert ER; Brown JP; Kaunitz AM; Wagner MS; Bérubé J; Charbonneau L; Francoeur D; Gilbert A; Gilbert F; Roy G; Senikas V; Jacob R; Morin R Contraception; 2009 Mar; 79(3):167-77. PubMed ID: 19185668 [TBL] [Abstract][Full Text] [Related]
11. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women. Gai L; Jia Y; Zhang M; Gai P; Wang S; Shi H; Yu X; Liu Y Contraception; 2012 Oct; 86(4):332-6. PubMed ID: 22364818 [TBL] [Abstract][Full Text] [Related]
12. Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study. Pongsatha S; Ekmahachai M; Chaovisitsaree S; Suntornlimsiri N; Morakote N J Med Assoc Thai; 2009 Oct; 92(10):1263-7. PubMed ID: 19845231 [TBL] [Abstract][Full Text] [Related]
13. Injectable contraception. Roy G Semin Reprod Med; 2010 Mar; 28(2):126-32. PubMed ID: 20352562 [TBL] [Abstract][Full Text] [Related]
14. The effect of hormonal oral contraception on acquisition of peak bone mineral density of adolescents and young women. Ziglar S; Hunter TS J Pharm Pract; 2012 Jun; 25(3):331-40. PubMed ID: 22572223 [TBL] [Abstract][Full Text] [Related]
15. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population. Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124 [TBL] [Abstract][Full Text] [Related]
16. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate. Clark MK; Sowers M; Levy B; Nichols S Fertil Steril; 2006 Nov; 86(5):1466-74. PubMed ID: 16996507 [TBL] [Abstract][Full Text] [Related]
17. Bone mineral density in adolescent and young adult women on injectable or oral contraception. Cromer BA Curr Opin Obstet Gynecol; 2003 Oct; 15(5):353-7. PubMed ID: 14501237 [TBL] [Abstract][Full Text] [Related]
18. [Depot medroxyprogesterone acetate (DMPA) injectable contraception--safe, effective but neglected method of family planning in Poland]. Lech MM Wiad Lek; 2003; 56(7-8):362-8. PubMed ID: 14969166 [TBL] [Abstract][Full Text] [Related]
19. Biopsychosocial variables associated with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate in adolescents: adolescents who lost 5% or more from baseline vs. those who lost less than 5%. Harel Z; Wolter K; Gold MA; Cromer B; Stager M; Johnson CC; Brown R; Bruner A; Coupey S; Hertweck P; Bone H; Burkman R; Nelson A; Marshall S; Bachrach LK Contraception; 2010 Dec; 82(6):503-12. PubMed ID: 21074012 [TBL] [Abstract][Full Text] [Related]
20. Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density. Johnson CC; Burkman RT; Gold MA; Brown RT; Harel Z; Bruner A; Stager M; Bachrach LK; Hertweck SP; Nelson AL; Nelson DA; Coupey SM; McLeod A; Bone HG Contraception; 2008 Apr; 77(4):239-48. PubMed ID: 18342646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]